{"id":"AIBD-0659","title":"AlphaFold models of TAAR1 yield psychotropic agonists at a 60% hit rate, more than twice the homology model's","summary":"Uppsala and Karolinska researchers docked compounds against AlphaFold models of TAAR1; 18 of 30 tested were agonists (60%), against 22% from a homology model.","date_observed":"2024-08-07","date_basis":"source publication","date_precision":"day","benefit_status":"reported","source_collection":null,"source_entry":null,"account":"Researchers at Uppsala University and the Karolinska Institutet in Sweden ran parallel virtual screens of large chemical libraries against AlphaFold models and traditional homology models of the trace amine-associated receptor 1 (TAAR1), a target for neuropsychiatric drugs without an experimental structure at the time. They tested 30 top-ranked compounds from the AlphaFold screen and 32 from the homology screen. Eighteen AlphaFold compounds were TAAR1 agonists, a hit rate of 60%, against seven homology compounds (22%), and the three most potent agonists came from the AlphaFold screen. One agonist with a good selectivity profile changed body temperature and showed antipsychotic-like effects in wild-type mice, with no such effect in TAAR1 knockout mice. Science Advances published the study on 7 August 2024. The authors tested the lead only in mice, and they state that AlphaFold was designed to predict a single static structure. Five authors are inventors on a patent application that covers compounds from the study.","category":"benefit created","unexpected":false,"purpose":"AlphaFold was built to predict protein structures. The researchers used the predictions for drug discovery, an application by an independent group.","system":"AlphaFold (AlphaFold2) predicted TAAR1 structures used for virtual screening","model_version":null,"developer":"DeepMind","deployer":"Uppsala University (Carlsson laboratory, Science for Life Laboratory) and Karolinska Institutet (Svenningsson laboratory)","location":"Uppsala and Stockholm, Sweden","domain":"Drug discovery","segment":null,"benefit_type":"Improved Knowledge Discovery","taxonomy_note":null,"registry_ids":{},"ratings":[{"group":"societal","depth":2,"reason":"The AlphaFold screen found 18 new TAAR1 agonists and a lead with antipsychotic-like effects in mice."}],"ai_role":{"status":"assessed","statement":"The researchers ran the same screen against AlphaFold models and homology models and tested compounds from both, so they isolate the contribution of the AlphaFold structure."},"evidence":[{"kind":"peer-reviewed study","citation":"Díaz-Holguín A, Saarinen M, Vo DD, et al. AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1. Sci Adv. 2024;10(32):eadn1524.","title":"AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11305387/","date":"2024-08-07","written_by":"deployer","quote":"The AlphaFold screen yielded a more than twofold higher hit rate (60%) than the homology model and discovered the most potent agonists."}],"replication":{"produced_by":["No experimental TAAR1 structure was available, so models were needed.","The team selected the AlphaFold models that best recognized known ligands before the prospective screen."],"must_hold":["The predicted binding site must be accurate in the region where ligands bind.","The target must have a buried pocket suited to docking."],"echoes":[{"date":"2024-06-21","setting":"UCSF-led docking against AlphaFold2 models of the sigma-2 and 5-HT2A receptors","model_version":null,"outcome":"recurred","source":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11253030/"}]},"paired_incident":null,"headline":"A predicted receptor shape speeds the search for psychiatric drug leads","metric":"Eighteen AlphaFold compounds were TAAR1 agonists, a hit rate of 60%","comparator":{"against":"Screen against homology models of TAAR1","before":"22% hit rate (7 of 32 compounds)","after":"60% hit rate (18 of 30 compounds)","basis":"measured","quote":"However, even if the hit rate was adjusted for this overlap, the AlphaFold model (54% adjusted hit rate) performed better than the homology model (22% adjusted hit rate).","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11305387/"},"later":null,"value":null,"developer_country":"United Kingdom","deployer_country":"Sweden","unrated_because":null,"brief_notes":null,"brief":null,"revisions":[{"date":"2026-10-29","change":"Added the case.","source":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11305387/","editor":"AIBD"}],"confidence":"claimed","shade":"low","claim_status":"The deployer's account","claim_basis":"Sources: the deployer's peer-reviewed study. The cited evidence includes no independent source and no finding by a regulator or court.","case_jurisdictions":["Sweden"],"profile":{"case_id":"AIBD-0659","catalog_version":"1.0.0","source_fingerprint":"80c628e5b7bffda9654c40f91a4eca58593555f97f8c48f0a05bd21c45567dc0","collection_refs":[{"collection_id":"aibd","version":"2026-10-29"},{"collection_id":"viator","version":"2026-10-25"}],"source_ids":["AIBD-0659-source-0001"],"families":{"strategic assessments":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]},"evaluations":{"state":"value_present","value":{"kind":"identifiers","identifiers":["AIBD-0659-evaluation-1"],"role":"Evaluations of the benefit"},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":[],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"partial","record_ids":["AIBD-0659-evaluation-1"]},"monetary observations":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]},"institutional decisions":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]}},"fields":{"actors[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"developer":"DeepMind","deployer":"Uppsala University (Carlsson laboratory, Science for Life Laboratory) and Karolinska Institutet (Svenningsson laboratory)"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["developer","deployer"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"actors[].ownership_control":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"ai_contribution":{"state":"value_present","value":{"kind":"record_fields","fields":{"ai_role":{"status":"assessed","statement":"The researchers ran the same screen against AlphaFold models and homology models and tested compounds from both, so they isolate the contribution of the AlphaFold structure."}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ai_role"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"ai_relationship":{"state":"value_present","value":{"kind":"record_fields","fields":{"category":"benefit created","ai_role":{"status":"assessed","statement":"The researchers ran the same screen against AlphaFold models and homology models and tested compounds from both, so they isolate the contribution of the AlphaFold structure."}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ai_role","category"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].alternatives":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].assessor_date":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].depth":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"societal","depth":2,"reason":"The AlphaFold screen found 18 new TAAR1 agonists and a lead with antipsychotic-like effects in mice."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].display_confidence":{"state":"value_present","value":{"kind":"structured","data":{"confidence":"low","evidence_word":"claimed","claim_status":"The deployer's account","basis":"Sources: the deployer's peer-reviewed study. The cited evidence includes no independent source and no finding by a regulator or court.","interpretation":"Existing display rule preserved; the richer outcome-specific confidence question still needs review."}},"provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].rationale":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"societal","depth":2,"reason":"The AlphaFold screen found 18 new TAAR1 agonists and a lead with antipsychotic-like effects in mice."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].rubric_version":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].status_basis":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].target":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"societal","depth":2,"reason":"The AlphaFold screen found 18 new TAAR1 agonists and a lead with antipsychotic-like effects in mice."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"availability":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"brief":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"case_kind":{"state":"value_present","value":{"kind":"structured","data":{"classification":"evaluation or study","answer":"The case describes an evaluation or a study. A prospective comparison of two kinds of structural models.","scope":"The period and activity described in the case."}},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["account","evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"The case describes an evaluation or a study. A prospective comparison of two kinds of structural models.","inferred":false}},"case_links[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Compared with the incidents in the AI Incident Database snapshot of 26 October 2026.","record_fields":["paired_incident"],"source_refs":[]},"reason":"No incident in the AI Incident Database snapshot of 26 October 2026 concerns the same kind of system harming the same kind of stakeholder.","review_state":"reviewed","coverage":"partial"},"claims[].evidence_links":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"claims[].evidence_strength":{"state":"value_present","value":{"kind":"structured","data":{"answer":"The deployer's account. Sources: the deployer's peer-reviewed study. The cited evidence includes no independent source and no finding by a regulator or court.","evidence_word":"claimed","claim_status":"The deployer's account"}},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"The deployer's account. Sources: the deployer's peer-reviewed study. The cited evidence includes no independent source and no finding by a regulator or court.","inferred":false}},"claims[].missingness":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"claims[].proposition":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"cross_border_flows[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"decisions[].action_outcome":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"decisions[].grounds":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"decisions[].institution_task":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"decisions[].success_criterion":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"deployment_stage":{"state":"value_present","value":{"kind":"structured","data":{"classification":"laboratory test","answer":"The system was tested in a laboratory. Virtual screening with cell assays and mouse experiments.","scope":"The period and activity described in the case."}},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["account","evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"The system was tested in a laboratory. Virtual screening with cell assays and mouse experiments.","inferred":false}},"economics[].amount":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].costs[]":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].counterfactual":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].currency_price_basis":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].gross_net":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].measure_type":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].period_unit":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].realization":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].recipient_payer":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].return_payback":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].valuation_method":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"evaluations[].ai_uplift":{"state":"value_present","value":{"kind":"text","text":"More than twofold higher hit rate."},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"More than twofold higher hit rate.","inferred":false}},"evaluations[].comparator":{"state":"value_present","value":{"kind":"text","text":"Homology-model screen."},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"Homology-model screen.","inferred":false}},"evaluations[].design":{"state":"value_present","value":{"kind":"text","text":"Controlled observational."},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"Controlled observational.","inferred":false}},"evaluations[].effect":{"state":"value_present","value":{"kind":"text","text":"60% against 22% (54% against 22% after adjusting for overlap)."},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"60% against 22% (54% against 22% after adjusting for overlap).","inferred":false}},"evaluations[].exposure":{"state":"value_present","value":{"kind":"text","text":"Laboratory screening."},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"Laboratory screening.","inferred":false}},"evaluations[].id":{"state":"value_present","value":{"kind":"identifiers","identifiers":["AIBD-0659-evaluation-1"],"role":"Evaluations of the benefit"},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"Controlled observational.","inferred":false}},"evaluations[].measurement_method":{"state":"value_present","value":{"kind":"text","text":"Cell-based TAAR1 activation assays of docked compounds; mouse behavior and temperature tests for one lead."},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"Cell-based TAAR1 activation assays of docked compounds; mouse behavior and temperature tests for one lead.","inferred":false}},"evaluations[].metric":{"state":"value_present","value":{"kind":"text","text":"Agonist hit rate and potency."},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"Agonist hit rate and potency.","inferred":false}},"evaluations[].reproduction_materials":{"state":"value_present","value":{"kind":"text","text":"Compound data in the paper and supplement."},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"Compound data in the paper and supplement.","inferred":false}},"evaluations[].setting_sample":{"state":"value_present","value":{"kind":"text","text":"30 AlphaFold and 32 homology-model compounds; wild-type and TAAR1 knockout mice."},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"30 AlphaFold and 32 homology-model compounds; wild-type and TAAR1 knockout mice.","inferred":false}},"evaluations[].uncertainty_limitations":{"state":"value_present","value":{"kind":"text","text":"One receptor; small numbers tested; animal data only; five authors hold a patent application on the compounds."},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0659-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"One receptor; small numbers tested; animal data only; five authors hold a patent application on the compounds.","inferred":false}},"external_references[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"follow_up[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"human_oversight":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"id":{"state":"value_present","value":{"kind":"record_fields","fields":{"id":"AIBD-0659"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["id"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"infrastructure_dependencies[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].beneficiaries":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].beneficiary_count":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].benefit_type":{"state":"value_present","value":{"kind":"record_fields","fields":{"benefit_type":"Improved Knowledge Discovery"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["benefit_type"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].claim":{"state":"value_present","value":{"kind":"record_fields","fields":{"account":"Researchers at Uppsala University and the Karolinska Institutet in Sweden ran parallel virtual screens of large chemical libraries against AlphaFold models and traditional homology models of the trace amine-associated receptor 1 (TAAR1), a target for neuropsychiatric drugs without an experimental structure at the time. They tested 30 top-ranked compounds from the AlphaFold screen and 32 from the homology screen. Eighteen AlphaFold compounds were TAAR1 agonists, a hit rate of 60%, against seven homology compounds (22%), and the three most potent agonists came from the AlphaFold screen. One agonist with a good selectivity profile changed body temperature and showed antipsychotic-like effects in wild-type mice, with no such effect in TAAR1 knockout mice. Science Advances published the study on 7 August 2024. The authors tested the lead only in mice, and they state that AlphaFold was designed to predict a single static structure. Five authors are inventors on a patent application that covers compounds from the study.","benefit_type":"Improved Knowledge Discovery"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["account","benefit_type"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].distribution":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].duration":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].id":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].stakeholder_group":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"societal","depth":2,"reason":"The AlphaFold screen found 18 new TAAR1 agonists and a lead with antipsychotic-like effects in mice."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].status":{"state":"value_present","value":{"kind":"record_fields","fields":{"benefit_status":"reported"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["benefit_status"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].tradeoffs":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].unexpected":{"state":"value_present","value":{"kind":"record_fields","fields":{"unexpected":false,"purpose":"AlphaFold was built to predict protein structures. The researchers used the predictions for drug discovery, an application by an independent group."}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["unexpected","purpose"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"places[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"location":"Uppsala and Stockholm, Sweden","developer_country":"United Kingdom","deployer_country":"Sweden"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["location","developer_country","deployer_country"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"purpose":{"state":"value_present","value":{"kind":"record_fields","fields":{"purpose":"AlphaFold was built to predict protein structures. The researchers used the predictions for drug discovery, an application by an independent group."}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["purpose"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"record_dates":{"state":"value_present","value":{"kind":"record_fields","fields":{"date_observed":"2024-08-07","date_basis":"source publication","date_precision":"day","revisions":[{"date":"2026-10-29","change":"Added the case.","source":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11305387/","editor":"AIBD"}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["date_observed","date_basis","date_precision","revisions"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"replication.attempts[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"replication":{"produced_by":["No experimental TAAR1 structure was available, so models were needed.","The team selected the AlphaFold models that best recognized known ligands before the prospective screen."],"must_hold":["The predicted binding site must be accurate in the region where ligands bind.","The target must have a buried pocket suited to docking."],"echoes":[{"date":"2024-06-21","setting":"UCSF-led docking against AlphaFold2 models of the sigma-2 and 5-HT2A receptors","outcome":"recurred","source":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11253030/"}]}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["replication"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"replication.conditions":{"state":"value_present","value":{"kind":"record_fields","fields":{"replication":{"produced_by":["No experimental TAAR1 structure was available, so models were needed.","The team selected the AlphaFold models that best recognized known ligands before the prospective screen."],"must_hold":["The predicted binding site must be accurate in the region where ligands bind.","The target must have a buried pocket suited to docking."],"echoes":[{"date":"2024-06-21","setting":"UCSF-led docking against AlphaFold2 models of the sigma-2 and 5-HT2A receptors","outcome":"recurred","source":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11253030/"}]}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["replication"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"revision_history[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"revisions":[{"date":"2026-10-29","change":"Added the case.","source":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11305387/","editor":"AIBD"}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["revisions"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sector":{"state":"value_present","value":{"kind":"record_fields","fields":{"domain":"Drug discovery"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["domain"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sources[].access_version":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"sources[].citation_locator":{"state":"value_present","value":{"kind":"record_fields","fields":{"evidence":[{"kind":"peer-reviewed study","citation":"Díaz-Holguín A, Saarinen M, Vo DD, et al. AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1. Sci Adv. 2024;10(32):eadn1524.","title":"AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11305387/","date":"2024-08-07","written_by":"deployer","quote":"The AlphaFold screen yielded a more than twofold higher hit rate (60%) than the homology model and discovered the most potent agonists."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sources[].id":{"state":"value_present","value":{"kind":"identifiers","identifiers":["AIBD-0659-source-0001"],"role":"Existing evidence items, in their original order"},"provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"review_state":"record_mapped","coverage":"complete"},"sources[].language":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"sources[].relationship":{"state":"value_present","value":{"kind":"record_fields","fields":{"evidence":[{"kind":"peer-reviewed study","citation":"Díaz-Holguín A, Saarinen M, Vo DD, et al. AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1. Sci Adv. 2024;10(32):eadn1524.","title":"AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11305387/","date":"2024-08-07","written_by":"deployer","quote":"The AlphaFold screen yielded a more than twofold higher hit rate (60%) than the homology model and discovered the most potent agonists."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sources[].upstream_sources":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"strategic_assessments[]":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"strategic assessments"},"summary":{"state":"value_present","value":{"kind":"record_fields","fields":{"summary":"Uppsala and Karolinska researchers docked compounds against AlphaFold models of TAAR1; 18 of 30 tested were agonists (60%), against 22% from a homology model.","account":"Researchers at Uppsala University and the Karolinska Institutet in Sweden ran parallel virtual screens of large chemical libraries against AlphaFold models and traditional homology models of the trace amine-associated receptor 1 (TAAR1), a target for neuropsychiatric drugs without an experimental structure at the time. They tested 30 top-ranked compounds from the AlphaFold screen and 32 from the homology screen. Eighteen AlphaFold compounds were TAAR1 agonists, a hit rate of 60%, against seven homology compounds (22%), and the three most potent agonists came from the AlphaFold screen. One agonist with a good selectivity profile changed body temperature and showed antipsychotic-like effects in wild-type mice, with no such effect in TAAR1 knockout mice. Science Advances published the study on 7 August 2024. The authors tested the lead only in mice, and they state that AlphaFold was designed to predict a single static structure. Five authors are inventors on a patent application that covers compounds from the study."}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["summary","account"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"systems[].autonomy_permissions":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].component_role":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].deployment_configuration":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].inputs_outputs":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].model_name":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].model_version":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].product_name":{"state":"value_present","value":{"kind":"record_fields","fields":{"system":"AlphaFold (AlphaFold2) predicted TAAR1 structures used for virtual screening"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["system"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"systems[].provider":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"taxonomy_crosswalks[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"title":{"state":"value_present","value":{"kind":"record_fields","fields":{"title":"AlphaFold models of TAAR1 yield psychotropic agonists at a 60% hit rate, more than twice the homology model's","headline":"A predicted receptor shape speeds the search for psychiatric drug leads"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["title","headline"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"version":{"state":"value_present","value":{"kind":"identifiers","identifiers":["c900fabcb1c5404c6f8be134b28f6d430f479bc4fe04eb7cecf37688efae0ca0"],"role":"SHA-256 of the complete public case and its assessments"},"provenance":{"kind":"curatorial","basis":"SHA-256 of the public case, its assessments, and its displayed answers and notes, excluding its own identifier and the derived coverage summary.","record_fields":[],"source_refs":[]},"review_state":"record_mapped","coverage":"complete"},"workflow":{"state":"value_present","value":{"kind":"record_fields","fields":{"account":"Researchers at Uppsala University and the Karolinska Institutet in Sweden ran parallel virtual screens of large chemical libraries against AlphaFold models and traditional homology models of the trace amine-associated receptor 1 (TAAR1), a target for neuropsychiatric drugs without an experimental structure at the time. They tested 30 top-ranked compounds from the AlphaFold screen and 32 from the homology screen. Eighteen AlphaFold compounds were TAAR1 agonists, a hit rate of 60%, against seven homology compounds (22%), and the three most potent agonists came from the AlphaFold screen. One agonist with a good selectivity profile changed body temperature and showed antipsychotic-like effects in wild-type mice, with no such effect in TAAR1 knockout mice. Science Advances published the study on 7 August 2024. The authors tested the lead only in mice, and they state that AlphaFold was designed to predict a single static structure. Five authors are inventors on a patent application that covers compounds from the study.","replication":{"produced_by":["No experimental TAAR1 structure was available, so models were needed.","The team selected the AlphaFold models that best recognized known ligands before the prospective screen."],"must_hold":["The predicted binding site must be accurate in the region where ligands bind.","The target must have a buried pocket suited to docking."],"echoes":[{"date":"2024-06-21","setting":"UCSF-led docking against AlphaFold2 models of the sigma-2 and 5-HT2A receptors","outcome":"recurred","source":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11253030/"}]}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["account","replication"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"}},"summary":{"total":91,"addressed":91,"known":42,"reviewed":15,"reviewed_complete":14,"reviewed_partial":1,"record_mapped":28,"review_not_assessed":48,"not_assessed":0,"complete":false,"by_state":{"value_present":42,"not_reported":0,"unresolved":49,"not_assessed":0,"not_applicable":0,"withheld":0,"source_unavailable":0}}},"presentation_version":"4d51042b5a554b41206c7768f3a78b8087347e6cc4d9af5539102bddd7b6b4f4"}